BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

PARTNERSHIPS

Business Development Opportunities

Working together to improve the lives of patients living with serious and debilitating chronic conditions.

BDSI actively seeks partnerships and product licenses in the areas of neurology, pain, psychiatry, and select rare diseases. We collaborate in ways that expand and strengthen the process of commercializing innovative therapies, and are open to working within a variety of mutually beneficial deal structures.

Working With BDSI

For more information on the growing BDSI portfolio, or to explore partnership opportunities, please contact Kevin Ostrander.

Kevin Ostrander, SVP, Business Development 4131 Parklake Avenue, Suite 225 Raleigh, NC 27612 Tel: 919-582-9050

Asterisks denote required fields

Recent BDSI News

April 20, 2021

RALEIGH, N.C. , April 20, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its first quarter 2021

Read more
March 10, 2021

Total Company Net Revenue Increased 40% versus Prior Year to Reach an All-Time High of $156.5 Million Record Level Profitability with Net Income of $25.7 Million , Full-Year EBITDA Margin of 26% and Operating Cash Generation of $25 Million Conference Call and Webcast Scheduled for 8:30 AM EST Today

Read more
February 17, 2021

RALEIGH, N.C. , Feb. 17, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its fourth quarter and full

Read more
More news

Upcoming Events

BDSI First Quarter 2021 Financial Results Call and Webcast May 6, 2021 8:30 AM EDT

Stay Connected

Stay up to date on the latest news

Get started now
April 21, 2021BDSI $3.42/ - 0%
Data provided by Nasdaq. Minimum 15 minutes delayed.